Background: Cancer is one of the most challenging diseases to treat and is characterized by abnormal and invasive growth and cellular metabolism reprogramming. To overcome these cancers, chemotherapy, surgery, and radiation therapy are the most common...
Background: Cancer is one of the most challenging diseases to treat and is characterized by abnormal and invasive growth and cellular metabolism reprogramming. To overcome these cancers, chemotherapy, surgery, and radiation therapy are the most common types of cancer treatments available today. However, these methods can cause immediate side effects and aftereffects of cancer treatment. Accordingly, research on cancer prevention and treatment using natural-derived substances to minimize side effects is being actively studied. Hydrocotyle umbellata is an aquatic plant belonging to Araliaceae and is known to have anti-anxiety, analgesic, and anti-inflammatory effects. However, the effect on cancer prevention and treatment is not well known. This study investigated the effect of H.umbellata on cancer growth and metabolism.
Methods: The leaves and stems of H.umbellata were freeze-dried after high pressure and high-temperature extraction. In vitro, the following experiment was conducted: cell growth measurement through cell counting, OCR and ECAR measurement through real-time cell metabolism assay, reactive oxygen species measurements, apoptosis, and measurement through metabolism-related gene through qRT-PCR analysis & western blot. The major components of H.umbellata were analyzed and separated through UPLC-PDA-QToF-MS. In vivo experiments, cancer cells and H.umbellata extract were injected into the mouse abdominal cavity or subcutaneous cavity to measure the weight of cancer masses.
Results: When H.umbellata's leaves and stem extracts were treated on cancer cells, growth decreased significantly, but the noncancerous cells, NIH3T3 cells (mouse fibroblast), had no noticeable growth difference. Based on these results, in vivo experiment was also conducted. This experiment confirmed that injecting B16F10 cells and H.umbellata extract into the mouse reduced cancer weight. The decrease in cancer cell proliferation is due to up-regulating expression level of PDK by H.umbellata extract, thereby reducing the expression of PDH, resulting in a decrease in ATP production due to oxidative phosphorylation occurring in mitochondria. ROS was also reduced due to mitochondrial dysfunction. The treatment of H.umbellata extract and 2-DG, glycolysis inhibitor, together on B16F10 cells showed more effective growth inhibition and cell death synergies than the treatment of the two substances alone. As a result, when analyzing the major components of H.umbellata, found 1,3,4-trihydroxy-2-butanyl-α-D-glucopyranoside and caffeoylquinic derivatives have anti-cancer effects.
Conclusions: This study suggests that H.umbellata regulates cell metabolism, causing mitochondrial dysfunction and inhibiting cancer cell growth.